# Dutch Pancreatic Cancer Group

Source: https://onco.cc/companies/dpcg/  
OnCo record `dpcg` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The Dutch Pancreatic Cancer Group is the national Dutch collaboration of pancreatic cancer surgeons, oncologists and researchers that ran PREOPANC, the trial that established neoadjuvant chemoradiotherapy for resectable pancreatic cancer.

## Summary

The Dutch Pancreatic Cancer Group (DPCG) is the Dutch multidisciplinary collaboration for pancreatic cancer, with its address at Amsterdam UMC, De Boelelaan 1117-1118, Amsterdam, and contact points at the LUMC in Leiden and Radboudumc in Nijmegen (dpcg.nl). No founding year is stated on the pages read. In OnCo it is the sponsor of PREOPANC-1 and PREOPANC-2 (Netherlands Trial Register NTR3709), the phase 3 trials of preoperative chemoradiotherapy and of neoadjuvant FOLFIRINOX in resectable and borderline resectable pancreatic cancer. It has no products of its own.

## Fields

- Kind: Company
- Last checked: 2026-09-25
- Also known as: DPCG
- Tags: ctgov-sponsor; cooperative-group
- HQ: Amsterdam
- Type: cooperative-group
- Website: https://dpcg.nl

## Sources

- Official website: https://dpcg.nl
- ClinicalTrials.gov: trials led by Dutch Pancreatic Cancer Group: https://clinicaltrials.gov/search?lead=Dutch%20Pancreatic%20Cancer%20Group

## Connected records

- cancers: [Borderline resectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/borderline-resectable-pdac/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/), [Resectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/resectable-pdac/)
- institutions: [Amsterdam UMC / Cancer Center Amsterdam](https://onco.cc/institutions/amsterdam-umc/)
- trials: [PREOPANC-1 / PREOPANC-2](https://onco.cc/trials/preopanc/)

---
JSON: https://onco.cc/api/v1/entities/dpcg.json